Company / PP&E (Net)
Prime Medicine, Inc. PP&E (Net) History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$24.4M
FY2024
5-year range
$4.9M / $24.4M
FY2021-FY2024
Trend
+7.7%
vs FY2023
Sector context
#78 of 197
Health Care
What the data says
At $24M, Prime Medicine, Inc.'s pp&e (net) ranks #78 of 197 in the Health Care sector. PP&E (Net) has increased for 3 consecutive years, from $5M in FY2021 to $24M in FY2024.
Based on SEC 10-K filings.
$24M in FY2024 with a 3-year CAGR of +70.4%.
Improved from $19M to $24M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +70.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#78 of 197 in Health CareTop 40% of 197This company $24.4M Sector average $773.5M
▼
-96.8% below sector average
Key checks
Key Insights
- Prime Medicine, Inc.'s pp&e (net) has grown for 3 consecutive years.
- 3-year CAGR of +70.4%, indicating consistent growth.
- In FY2024, pp&e (net) increased 7.7% year-over-year.
- Ranks #78 out of 197 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -1.24 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | $24.4M | +7.7% |
| FY2023 | $22.7M | +19.2% |
| FY2022 | $19.0M | +285.4% |
| FY2021 | $4.9M | - |
| FY2020 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026